Clinical Trials Directory

Trials / Unknown

UnknownNCT00452049

The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure

Observational Study to Evaluate the Effect of Parathyroidectomy on Renal Function, Endothelial Function and Blood Pressure

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Secondary hyperparathyroidism (HPT) is a known complication of chronic renal failure. Elevated concentrations of parathyroid hormone (PTH) play a role not only in the pathogenesis of renal bone disease, but also in the development of cardiovascular risk factors such as disturbed lipid metabolism, glucose intolerance, and hypertension. HPT is also known to play an important role in the development of structural abnormalities of both large arteries and the heart (left ventricular hypertrophy, interstitial fibrosis). In the last couple of years there has been increasing evidence from animal studies that the endothelium is a target organ of PTH. Hypothesis: PTH has clinically relevant effects on renal hemodynamics, renal function and endothelial function. Aims: 1. To evaluate the effect of parathyroidectomy (PTX) on renal hemodynamics in stable renal transplant recipients 2. To evaluate the effect of PTX on endothelial function in stable renal transplant recipients/chronic kidney disease (CKD) stage 5 patients 3. To evaluate the effect of PTX on blood pressure in stable renal transplant recipients/CKD stage 5 patients

Conditions

Interventions

TypeNameDescription
PROCEDUREparathyroidectomyparathyroidectomy

Timeline

Start date
2005-04-01
First posted
2007-03-26
Last updated
2012-05-30

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00452049. Inclusion in this directory is not an endorsement.